We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Heart Cdi 35:1 | ASX:HIN | Australian Stock Exchange | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
DOW JONES NEWSWIRES
Thoratec Corp. (THOR) said it ended its $282-million bid to acquire medical-device maker HeartWare International Inc. (HTWR) after the Federal Trade Commission said it would challenge the deal in court.
HeartWare's shares fell 4.9% to $21.60 in after-hours trading, while Thoratec's shares were inactive after closing at $25.14.
The FTC on Wednesday alleged that Thoratec's takeover of HeartWare would further the company's monopoly in the market for left ventrical devices, surgically implanted blood pumps that support and sustain patients suffering from end-stage heart failure.
Thoratec is the only company that has Food and Drug Administration approval to sell left ventrical devices. HeartWare is one of the few other makers of these devices.
Thoratec Chief Executive Gary F. Burbach said the company's management and board decided it was in the best long-term interests of the company and its shareholders not to pursue "what would likely be a protracted, costly and unpredictable litigation process."
HeartWare CEO Doug Godshall said his company agreed that litigation wasn't in the best interests of shareholders. "While we, too, are disappointed with the decision by the FTC, we are, nonetheless, excited about HeartWare's prospects going forward on a stand-alone basis," he said.
-By Kathy Shwiff, Dow Jones Newswires; 201-938-5975; Kathy.Shwiff@dowjones.com
1 Year Heartware International Chart |
1 Month Heartware International Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions